Inhibitors of fibrinolysis: drugs, mechanism of action, indications

The Word "fibrinolysis" in Greek means "decomposition" or "dissolution". This process of breaking up of blood clots and thrombi, which is part of homeostasis and is accompanied by clotting. For man is a natural protective reaction of the organism. It prevents blood clots and promotes cell regeneration after heavy blood loss. Inhibitors of fibrinolysis are a group of drugs that have a hemostatic effect.

What this is

Inhibitors of fibrinolysis to stop bleeding in different pathological conditions of the patient. Widely used during and after surgery. Using the procedure of fibrinolysis dissolves clots, break down clots, preventing blockage of blood vessels. Fibrinolysis helps to restore blood vessels, after blood loss. The process for internal and external mechanism. In the first case, the regeneration activators responsible plasma, erythrocytes, platelets, leukocytes. Due to the internal mechanism, the vessels are cleaned from the formed in the coagulation of fibrin. In the second case, in the process of recovery of tissue activators. These include plasminogen and urokinase.

In the body the processes of fibrinolysis and coagulation of blood are in harmony. If a person has an active sympathetic nervous system, blood comes adrenaline and noradrenaline, that is, run internal and external mechanisms that induce fibrinolysis. If the increased tone of the parasympathetic nervous system, accelerating the blood coagulation. In a healthy person there is a balance between coagulation and fibrinolysis, its liquefaction. If this connection is broken, might cause a blood clot or a dangerous disease like hemophilia. Drugs inhibitors of fibrinolysis are designed to break down clots and help the body, if the balance between the two processes was broken. The use of these substances is allowed only upon the recommendation of the attending physician.

A tablet from worms – the relevance of the application for the person

How relevant today, drugs against worms in humans? What kind of creatures these worms, what are modern methods of treatment? We will try to answer these questions, since ignorance in this area is undesirable. Imagine a mummy, which is misleading in k...

What to do if you cracked skin on hands?

Each of us at least once in a lifetime encounter with a small, but very, when the crack the skin on the hands. At this time there are wounds of different sizes, which hurt and cause inconvenience, especially when in contact with water or detergents. ...

Spray Macho man - the key to a proper relationship between the two spouses

Male impotence is a pathological condition associated with abnormal physiological capacity of the penis to reginout and bring sexual partner pleasure in bed.sex impotenceimpotence may not men to pass unnoticed – it usually spoils his nervous sy...

Properties

Inhibitors of fibrinolysis inhibit the process of blood thinning. They prevent the formation of acids and plazminogenaktiviruyuschego of the enzyme. The inhibitors are designed to stop bleeding in various pathological conditions and also during surgery. In the process of fibrinolysis involves the proteolytic proteins which inhibit the blood thinners, but improve its clotting. Plasmin is considered to be the main catalyst in fibrinolysis. It is on the contrary, decomposes fibrin. The inhibitors reduce the activity of plasminogen.

How to apply

Inhibitors of fibrinolysis are hemostatic. They have the ability to inhibit fibrinolysis, inhibiting the action of plasmin and plasminogen activators. To the group of inhibitors include aminocaproic acid and Aprotinin. Drugs block plasminogen not allowed to break down formed clots. Aminocaproic acid increases the level of plasmin, inhibits the secretion of urokinase. If you experience bleeding, acid leads to normal fibrinogen level. The substance is rapidly absorbed in the gastrointestinal tract. The maximum concentration in the blood reaches the acid within two hours after ingestion. If you take the drug orally, approximately sixty percent is excreted by the kidneys. The mechanism of action of inhibitors of fibrinolysis simple: gemostatiki block plasminogen, inhibit the breakdown of blood. In pathological States high fibrinolysis causing serious, sometimes fatal bleeding. They arise because of injuries to internal organs, overdose of coagulants. Inhibitors of the function of quickly stopping the blood loss.

Indications

In some cases, prescribed to inhibitors of fibrinolysis? Indications for the use of these drugs is as follows:

• Excessive bleeding associated with high fibrinolytic activity of blood.
• Blood loss after surgery (operations on the lungs, thyroid and pancreatic glands, removal of the prostate)
• Detachment of the placenta. Finding a dead fetus in the uterus a long time.
• Cirrhosis of the liver, kidney disease.
• Pancreatitis.
• Ulcers of the stomach and duodenum.
• Sepsis.

Inhibitors are Taken as tablets or intravenously.

Contraindications

Strict adherence to the instructions for use of injections "Amen" and other inhibitors, as well as established physician dosage will help to avoid severe side effects and other problems. It should be noted that each of the drug its own characteristics. For example, aminocaproic acid is not toxic to humans. If the dose is set small, the patient will not notice any negative side effects. It is prohibited to assign the inhibitors to people with a propensity for embolism and thrombosis, patients with impaired renal function and liver, during pregnancy. Careful preparation of fibrinolysis used in the pathology of cerebral circulation, cardiovascular diseases. It is important to monitor the patient throughout the therapeutic period and testthe content of fibrinogen in the blood.

The Solution of aminocaproic acid, as with other drugs inhibitors, have side effects. They occur if a patient is prescribed a normal dose, and also at infringement of function of kidneys. To side effects of inhibitors include allergic reactions, airway inflammation, skin rashes, nasal congestion, ringing in the ears, burning eyes and redness, nausea, diarrhea, fluctuations in blood pressure, dizziness, weakness, heart rhythm disturbances. Do not take the Aprotinin and aminocaproic acid. This leads to the formation of blood clots.

Drug List

Drugs are your doctor if you experience bleeding, for prophylaxis, after surgery, including operations on the organs that have a lot of tissue activators of fibrinolysis. For example, aminocaproic acid oral take fifteen grams per day, separating techniques. Drip to impose a five per cent solution of 100 ml. the Dose is determined individually. The course of treatment with inhibitors ranges from six days to four weeks.

The classification of inhibitors of fibrinolysis lies pharmacological action. Every drug has it own. Substances in this group are opposed fibrinolitikami. The inhibitors stop the bleeding and stabilize the fibrin. To a group of medicines referred traneksamova and aminocaproic acid, paraaminobenzoic acid. Aprotinin is a natural inhibitor of trypsin and plasmin. Thanks to them, reduced the level of proteases in blood and tissues, relieves inflammation in the pancreas. These products are recommended in hemorrhages that cause surgery, trauma, childbirth, and complications after thrombolytic therapy. The preparations of the inhibitors of fibrinolysis include "Amber", "Gordox", "Contrical 10000", "Protex", "Aerus", "Gumbys", "Ingitril", "Pemba", "Restaurant", "Traneksam", "Azazil", "Tracklen" and others.

Aminocaproic acid

Like other inhibitors, is used for bleeding and internal organ diseases. The drug is available in the form of a crystalline powder. Has no taste, odour and colour, well soluble in water. You can not use with hypersensitivity, during pregnancy. Has a number of side effects.

Aprotinin

Inhibitor of of broad spectrum. Appointed with abundant blood loss, pancreatitis, post-operative, post-traumatic hemorrhage, angioedema, shock after burns, traumas, intoxications, to prevent emboli, as additional therapy. In the instructions for use of injections "Amen" it is said that they are also prescribed for bleeding (postoperative, uterine, gastrointestinal, nasal), leukemia, sepsis.

Traneksam

This is a hemostatic drug transition of plasminogen to plasmin. Prevents the formation of kinins, which cause inflammation and allergies. Stops the blood loss, disease, acts as an analgesic. Prescribed for risk of bleeding against the backdrop of enhanced fibrinolysis, malignancy, inflammatory processes, allergic diseases. The dosage is determined individually. The drug there are contraindications and side effects of the cardiovascular, digestive, coagulation system, and Central nervous system. Should not be used if the patient has hypersensitivity to the medicine.